Abnormal Uterine Bleeding

Variant: 1 Abnormal uterine bleeding. Initial imaging.

Procedure	Appropriateness Category	Relative Radiation Level
US duplex Doppler pelvis	Usually Appropriate	O
US pelvis transabdominal	Usually Appropriate	O
US pelvis transvaginal	Usually Appropriate	O
US sonohysterography	May Be Appropriate (Disagreement)	O
MRI pelvis without and with IV contrast	Usually Not Appropriate	O
MRI pelvis without IV contrast	Usually Not Appropriate	O
CT pelvis with IV contrast	Usually Not Appropriate	☢☢☢
CT pelvis without IV contrast	Usually Not Appropriate	☢☢☢
CT pelvis without and with IV contrast	Usually Not Appropriate	☢☢☢☢

Variant: 2 Abnormal uterine bleeding. Follow-up imaging when original ultrasound is inconclusive or further imaging characterization is needed.

Procedure	Appropriateness Category	Relative Radiation Level
US sonohysterography	Usually Appropriate	O
MRI pelvis without and with IV contrast	Usually Appropriate	O
US duplex Doppler pelvis	May Be Appropriate (Disagreement)	O
US pelvis transabdominal	May Be Appropriate (Disagreement)	O
US pelvis transvaginal	May Be Appropriate (Disagreement)	O
MRI pelvis without IV contrast	May Be Appropriate (Disagreement)	O
CT pelvis with IV contrast	Usually Not Appropriate	☢☢☢
CT pelvis without IV contrast	Usually Not Appropriate	☢☢☢
CT pelvis without and with IV contrast	Usually Not Appropriate	☢☢☢☢

Variant: 3 Abnormal uterine bleeding. Follow-up imaging when surveillance is appropriate given findings from the initial ultrasound.

Procedure	Appropriateness Category	Relative Radiation Level
US duplex Doppler pelvis	Usually Appropriate	O
US pelvis transabdominal	Usually Appropriate	O
US pelvis transvaginal	Usually Appropriate	O
US sonohysterography	Usually Appropriate	O
MRI pelvis without and with IV contrast	Usually Appropriate	O
MRI pelvis without IV contrast	May Be Appropriate	O
CT pelvis with IV contrast	Usually Not Appropriate	☢☢☢
CT pelvis without IV contrast	Usually Not Appropriate	☢☢☢
CT pelvis without and with IV contrast	Usually Not Appropriate	☢☢☢☢

Panel Members

Summary of Literature Review

Introduction/Background

Special Imaging Considerations

Initial Imaging Definition

Initial imaging is defined as imaging at the beginning of the care episode for the medical condition defined by the variant. More than one procedure can be considered usually appropriate in the initial imaging evaluation when:

There are procedures that are equivalent alternatives (i.e., only one procedure will be ordered to provide the clinical information to effectively manage the patient’s care)

There are complementary procedures (i.e., more than one procedure is ordered as a set or simultaneously wherein each procedure provides unique clinical information to effectively manage the patient’s care).

Discussion of Procedures by Variant

Variant 1: Abnormal uterine bleeding. Initial imaging.

Variant 1: Abnormal uterine bleeding. Initial imaging.
A. CT Pelvis

Variant 1: Abnormal uterine bleeding. Initial imaging.
B. MRI Pelvis

Variant 1: Abnormal uterine bleeding. Initial imaging.
C. US Duplex Doppler Pelvis

Variant 1: Abnormal uterine bleeding. Initial imaging.
D. US Pelvis Transabdominal

Variant 1: Abnormal uterine bleeding. Initial imaging.
E. US Pelvis Transvaginal

Variant 1: Abnormal uterine bleeding. Initial imaging.
F. US Sonohysterography

Variant 2: Abnormal uterine bleeding. Follow-up imaging when original ultrasound is inconclusive or further imaging characterization is needed.

Variant 2: Abnormal uterine bleeding. Follow-up imaging when original ultrasound is inconclusive or further imaging characterization is needed.
A. CT Pelvis

Variant 2: Abnormal uterine bleeding. Follow-up imaging when original ultrasound is inconclusive or further imaging characterization is needed.
B. MRI Pelvis

Variant 2: Abnormal uterine bleeding. Follow-up imaging when original ultrasound is inconclusive or further imaging characterization is needed.
C. US Duplex Doppler Pelvis

Variant 2: Abnormal uterine bleeding. Follow-up imaging when original ultrasound is inconclusive or further imaging characterization is needed.
D. US Pelvis Transabdominal

Variant 2: Abnormal uterine bleeding. Follow-up imaging when original ultrasound is inconclusive or further imaging characterization is needed.
E. US Pelvis Transvaginal

Variant 2: Abnormal uterine bleeding. Follow-up imaging when original ultrasound is inconclusive or further imaging characterization is needed.
F. US Sonohysterography

Variant 3: Abnormal uterine bleeding. Follow-up imaging when surveillance is appropriate given findings from the initial ultrasound.

Variant 3: Abnormal uterine bleeding. Follow-up imaging when surveillance is appropriate given findings from the initial ultrasound.
A. CT Pelvis

Variant 3: Abnormal uterine bleeding. Follow-up imaging when surveillance is appropriate given findings from the initial ultrasound.
B. MRI Pelvis

Variant 3: Abnormal uterine bleeding. Follow-up imaging when surveillance is appropriate given findings from the initial ultrasound.
C. US Duplex Doppler Pelvis

Variant 3: Abnormal uterine bleeding. Follow-up imaging when surveillance is appropriate given findings from the initial ultrasound.
D. US Pelvis Transabdominal

Variant 3: Abnormal uterine bleeding. Follow-up imaging when surveillance is appropriate given findings from the initial ultrasound.
E. US Pelvis Transvaginal

Variant 3: Abnormal uterine bleeding. Follow-up imaging when surveillance is appropriate given findings from the initial ultrasound.
F. US Sonohysterography

Summary of Recommendations

Supporting Documents

The evidence table, literature search, and appendix for this topic are available at https://acsearch.acr.org/list. The appendix includes the strength of evidence assessment and the final rating round tabulations for each recommendation.

For additional information on the Appropriateness Criteria methodology and other supporting documents, please go to the ACR website at https://www.acr.org/Clinical-Resources/Clinical-Tools-and-Reference/Appropriateness-Criteria.

Appropriateness Category Names and Definitions

Appropriateness Category Name	Appropriateness Rating	Appropriateness Category Definition
Usually Appropriate	7, 8, or 9	The imaging procedure or treatment is indicated in the specified clinical scenarios at a favorable risk-benefit ratio for patients.
May Be Appropriate	4, 5, or 6	The imaging procedure or treatment may be indicated in the specified clinical scenarios as an alternative to imaging procedures or treatments with a more favorable risk-benefit ratio, or the risk-benefit ratio for patients is equivocal.
May Be Appropriate (Disagreement)	5	The individual ratings are too dispersed from the panel median. The different label provides transparency regarding the panel’s recommendation. “May be appropriate” is the rating category and a rating of 5 is assigned.
Usually Not Appropriate	1, 2, or 3	The imaging procedure or treatment is unlikely to be indicated in the specified clinical scenarios, or the risk-benefit ratio for patients is likely to be unfavorable.

Relative Radiation Level Information

Potential adverse health effects associated with radiation exposure are an important factor to consider when selecting the appropriate imaging procedure. Because there is a wide range of radiation exposures associated with different diagnostic procedures, a relative radiation level (RRL) indication has been included for each imaging examination. The RRLs are based on effective dose, which is a radiation dose quantity that is used to estimate population total radiation risk associated with an imaging procedure. Patients in the pediatric age group are at inherently higher risk from exposure, because of both organ sensitivity and longer life expectancy (relevant to the long latency that appears to accompany radiation exposure). For these reasons, the RRL dose estimate ranges for pediatric examinations are lower as compared with those specified for adults (see Table below). Additional information regarding radiation dose assessment for imaging examinations can be found in the ACR Appropriateness Criteria^® Radiation Dose Assessment Introduction document.

Relative Radiation Level Designations
Relative Radiation Level*	Adult Effective Dose Estimate Range	Pediatric Effective Dose Estimate Range
O	0 mSv	0 mSv
☢	<0.1 mSv	<0.03 mSv
☢☢	0.1-1 mSv	0.03-0.3 mSv
☢☢☢	1-10 mSv	0.3-3 mSv
☢☢☢☢	10-30 mSv	3-10 mSv
☢☢☢☢☢	30-100 mSv	10-30 mSv
*RRL assignments for some of the examinations cannot be made, because the actual patient doses in these procedures vary as a function of a number of factors (e.g., region of the body exposed to ionizing radiation, the imaging guidance that is used). The RRLs for these examinations are designated as “Varies.”

References

1.	Munro MG, Critchley HOD, Fraser IS, FIGO Menstrual Disorders Committee. The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions. Int J Gynaecol Obstet. 143(3):393-408, 2018 Dec.
2.	Munro MG, Critchley HO, Broder MS, Fraser IS, FIGO Working Group on Menstrual Disorders. FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. Int J Gynaecol Obstet. 113(1):3-13, 2011 Apr.
3.	Valentin L.. Imaging techniques in the management of abnormal vaginal bleeding in non-pregnant women before and after menopause. Best Pract Res Clin Obstet Gynaecol. 28(5):637-54, 2014 Jul.
4.	Dias DS, Bueloni-Dias FN, Dias R, et al. Usefulness of clinical, ultrasonographic, hysteroscopic, and immunohistochemical parameters in differentiating endometrial polyps from endometrial cancer. Journal of Minimally Invasive Gynecology. 21(2):296-302, 2014 Mar-Apr.
5.	Goldstein RB, Bree RL, Benson CB, et al. Evaluation of the woman with postmenopausal bleeding: Society of Radiologists in Ultrasound-Sponsored Consensus Conference statement. J Ultrasound Med. 2001 Oct;20(10):1025-36.
6.	Bayer SR, DeCherney AH. Clinical manifestations and treatment of dysfunctional uterine bleeding. JAMA. 1993; 269(14):1823-1828.
7.	Sweet MG, Schmidt-Dalton TA, Weiss PM, Madsen KP. Evaluation and management of abnormal uterine bleeding in premenopausal women. Am Fam Physician. 2012; 85(1):35-43.
8.	Brown DL, Packard A, Maturen KE, et al. ACR Appropriateness Criteria® First Trimester Vaginal Bleeding. J Am Coll Radiol 2018;15:S69-S77.
9.	American College of Radiology. ACR Appropriateness Criteria®: Second and Third Trimester Bleeding. Available at: https://acsearch.acr.org/docs/69465/Narrative/.
10.	ACOG Committee Opinion No. 734: The Role of Transvaginal Ultrasonography in Evaluating the Endometrium of Women With Postmenopausal Bleeding
11.	Ragupathy K, Cawley N, Ridout A, Iqbal P, Alloub M. Non-assessable endometrium in women with post-menopausal bleeding: to investigate or ignore. Archives of Gynecology & Obstetrics. 288(2):375-8, 2013 Aug.
12.	Kim YJ, Kim KG, Lee SR, Lee SH, Kang BC. Preoperative 3-dimensional Magnetic Resonance Imaging of Uterine Myoma and Endometrium Before Myomectomy. J Minim Invasive Gynecol. 24(2):309-314, 2017 02.
13.	Abbott JA.. Adenomyosis and Abnormal Uterine Bleeding (AUB-A)-Pathogenesis, diagnosis, and management. [Review]. Best Pract Res Clin Obstet Gynaecol. 40:68-81, 2017 Apr.
14.	Kierans AS, Bennett GL, Haghighi M, Rosenkrantz AB. Utility of conventional and diffusion-weighted MRI features in distinguishing benign from malignant endometrial lesions. Eur J Radiol. 83(4):726-32, 2014 Apr.
15.	Jha RC, Zanello PA, Ascher SM, Rajan S. Diffusion-weighted imaging (DWI) of adenomyosis and fibroids of the uterus. Abdom Imaging. 39(3):562-9, 2014 Jun.
16.	Lin G, Yang LY, Huang YT, et al. Comparison of the diagnostic accuracy of contrast-enhanced MRI and diffusion-weighted MRI in the differentiation between uterine leiomyosarcoma / smooth muscle tumor with uncertain malignant potential and benign leiomyoma. J Magn Reson Imaging. 43(2):333-42, 2016 Feb.
17.	Lakhman Y, Veeraraghavan H, Chaim J, et al. Differentiation of Uterine Leiomyosarcoma from Atypical Leiomyoma: Diagnostic Accuracy of Qualitative MR Imaging Features and Feasibility of Texture Analysis. European Radiology. 27(7):2903-2915, 2017 Jul.
18.	Tanaka T, Terai Y, Ono YJ, et al. Preoperative MRI and intraoperative frozen section diagnosis of myometrial invasion in patients with endometrial cancer. International Journal of Gynecological Cancer. 25(5):879-83, 2015 Jun.
19.	Mitamura T, Watari H, Todo Y, et al. Lymphadenectomy can be omitted for low-risk endometrial cancer based on preoperative assessments. Journal of Gynecologic Oncology. 25(4):301-5, 2014 Oct.
20.	Li HM, Liu J, Qiang JW, Zhang H, Zhang GF, Ma F. Diffusion-Weighted Imaging for Differentiating Uterine Leiomyosarcoma From Degenerated Leiomyoma. J Comput Assist Tomogr. 41(4):599-606, 2017 Jul/Aug.
21.	Sato K, Yuasa N, Fujita M, Fukushima Y. Clinical application of diffusion-weighted imaging for preoperative differentiation between uterine leiomyoma and leiomyosarcoma. Am J Obstet Gynecol. 210(4):368.e1-368.e8, 2014 Apr.
22.	Gaetke-Udager K, McLean K, Sciallis AP, et al. Diagnostic Accuracy of Ultrasound, Contrast-enhanced CT, and Conventional MRI for Differentiating Leiomyoma From Leiomyosarcoma. Acad Radiol. 23(10):1290-7, 2016 10.
23.	Thomassin-Naggara I, Dechoux S, Bonneau C, et al. How to differentiate benign from malignant myometrial tumours using MR imaging. Eur Radiol. 23(8):2306-14, 2013 Aug.
24.	Gupta A, Grunhagen T. Live MR angiographic roadmapping for uterine artery embolization: a feasibility study. J Vasc Interv Radiol. 24(11):1690-7, 2013 Nov.
25.	Kubik-Huch RA, Weston M, Nougaret S, et al. European Society of Urogenital Radiology (ESUR) Guidelines: MR Imaging of Leiomyomas. Eur Radiol. 28(8):3125-3137, 2018 Aug.
26.	Canverenler E, Buke B, Canverneler S. The Up to Date Status of Three-Dimensional Ultrasonography in Postmenopausal Bleeding. J Gynecol Neonatal 2017;1:101.
27.	El-Sherbiny W, El-Mazny A, Abou-Salem N, Mostafa WS. The diagnostic accuracy of two- vs three-dimensional sonohysterography for evaluation of the uterine cavity in the reproductive age. Journal of Minimally Invasive Gynecology. 22(1):127-31, 2015 Jan.
28.	Nergiz S, Demircan-Sezer S, Kucuk M, Yuksel H, Odabasi AR, Altinkaya SO. Comparison of diagnostic methods for evaluation of postmenopausal bleeding. European Journal of Gynaecological Oncology. 35(3):292-7, 2014.
29.	Nieuwenhuis LL, Bij de Vaate MA, Hehenkamp WJ, et al. Reproducibility of three-dimensional gel installation sonohysterography in the assessment and classification of intrauterine abnormalities. Eur J Obstet Gynecol Reprod Biol. 179:141-6, 2014 Aug.
30.	Fang L, Su Y, Guo Y, Sun Y. Value of 3-dimensional and power Doppler sonography for diagnosis of endometrial polyps. Journal of Ultrasound in Medicine. 32(2):247-55, 2013 Feb.
31.	Inoue T, Kitajima M, Taniguchi K, Masuzaki H. Three-dimensional saline-infusion sonohysterography is useful for the identification of endometrial polyp. Journal of Obstetrics & Gynaecology Research. 42(7):855-9, 2016 Jul.
32.	Czuczwar P, Wozniak S, Szkodziak P, Kudla MJ, Pyra K, Paszkowski T. Elastography Improves the Diagnostic Accuracy of Sonography in Differentiating Endometrial Polyps and Submucosal Fibroids. J Ultrasound Med. 35(11):2389-2395, 2016 Nov.
33.	Stoelinga B, Hehenkamp WJ, Brolmann HA, Huirne JA. Real-time elastography for assessment of uterine disorders. Ultrasound Obstet Gynecol. 43(2):218-26, 2014 Feb.
34.	Kabil Kucur S, Temizkan O, Atis A, et al. Role of endometrial power Doppler ultrasound using the international endometrial tumor analysis group classification in predicting intrauterine pathology. Archives of Gynecology & Obstetrics. 288(3):649-54, 2013 Sep.
35.	Timmerman D, Verguts J, Konstantinovic ML, et al. The pedicle artery sign based on sonography with color Doppler imaging can replace second-stage tests in women with abnormal vaginal bleeding. Ultrasound Obstet Gynecol. 2003; 22(2):166-171.
36.	Kamaya A, Yu PC, Lloyd CR, Chen BH, Desser TS, Maturen KE. Sonographic Evaluation for Endometrial Polyps: The Interrupted Mucosa Sign. Journal of Ultrasound in Medicine. 35(11):2381-2387, 2016 Nov.
37.	Dueholm M, Christensen JW, Rydbjerg S, Hansen ES, Ortoft G. Two- and three-dimensional transvaginal ultrasound with power Doppler angiography and gel infusion sonography for diagnosis of endometrial malignancy. Ultrasound in Obstetrics & Gynecology. 45(6):734-43, 2015 Jun.
38.	Kara Bozkurt D, Bozkurt M, Cil AS, Barut MU, Ersahin AA, Caliskan E. Concomitant use of transvaginal sonography and Doppler indices improve diagnosis of adenomyosis. Journal of Obstetrics & Gynaecology. 37(7):888-895, 2017 Oct.
39.	Dubinsky TJ. Value of sonography in the diagnosis of abnormal vaginal bleeding. J Clin Ultrasound. 2004; 32(7):348-353.
40.	Smith-Bindman R, Kerlikowske K, Feldstein VA, et al. Endovaginal ultrasound to exclude endometrial cancer and other endometrial abnormalities. JAMA. 1998; 280(17):1510-1517.
41.	Meredith SM, Sanchez-Ramos L, Kaunitz AM. Diagnostic accuracy of transvaginal sonography for the diagnosis of adenomyosis: systematic review and metaanalysis. Am J Obstet Gynecol. 2009; 201(1):107 e101-106.
42.	Wong AS, Lao TT, Cheung CW, et al. Reappraisal of endometrial thickness for the detection of endometrial cancer in postmenopausal bleeding: a retrospective cohort study. BJOG: An International Journal of Obstetrics & Gynaecology. 123(3):439-46, 2016 Feb.
43.	Breitkopf DM, Frederickson RA, Snyder RR. Detection of benign endometrial masses by endometrial stripe measurement in premenopausal women. Obstetrics & Gynecology. 104(1):120-5, 2004 Jul.
44.	Farquhar C, Ekeroma A, Furness S, Arroll B. A systematic review of transvaginal ultrasonography, sonohysterography and hysteroscopy for the investigation of abnormal uterine bleeding in premenopausal women. Acta Obstet Gynecol. Scand. 2003; 82(6):493-504.
45.	Ozdemir S, Celik C, Gezginc K, Kiresi D, Esen H. Evaluation of endometrial thickness with transvaginal ultrasonography and histopathology in premenopausal women with abnormal vaginal bleeding. Arch Gynecol Obstet. 2010; 282(4):395-399.
46.	Hulka CA, Hall DA, McCarthy K, Simeone JF. Endometrial polyps, hyperplasia, and carcinoma in postmenopausal women: differentiation with endovaginal sonography. Radiology. 1994; 191(3):755-758.
47.	Bazot M, Cortez A, Darai E, et al. Ultrasonography compared with magnetic resonance imaging for the diagnosis of adenomyosis: correlation with histopathology. Hum Reprod. 2001; 16(11):2427-2433.
48.	Guideline developed in collaboration with the American College of Radiology, American College of Obstetricians and Gynecologists, Society of Radiologists in Ultrasound. AIUM Practice Guideline for the Performance of Sonohysterography. Journal of Ultrasound in Medicine. 34(8):1-6, 2015 Aug.
49.	American College of Obstetricians and Gynecologists' Committee on Gynecologic Practice.. Technology Assessment No. 12: Sonohysterography. Obstetrics & Gynecology. 128(2):e38-42, 2016 08.
50.	Bhaduri M, Tomlinson G, Glanc P. Likelihood ratio of sonohysterographic findings for discriminating endometrial polyps from submucosal fibroids. J Ultrasound Med. 33(1):149-54, 2014 Jan.
51.	Bittencourt CA, Dos Santos Simoes R, Bernardo WM, et al. Accuracy of saline contrast sonohysterography in detection of endometrial polyps and submucosal leiomyomas in women of reproductive age with abnormal uterine bleeding: systematic review and meta-analysis. [Review]. Ultrasound Obstet Gynecol. 50(1):32-39, 2017 Jul.
52.	American College of Radiology. Manual on Contrast Media. Available at: https://www.acr.org/Clinical-Resources/Contrast-Manual.
53.	McComiskey MH, McCluggage WG, Grey A, Harley I, Dobbs S, Nagar HA. Diagnostic accuracy of magnetic resonance imaging in endometrial cancer. Int J Gynecol Cancer. 22(6):1020-5, 2012 Jul.
54.	American College of Radiology. ACR Appropriateness Criteria®: Pretreatment Evaluation and Follow-Up of Endometrial Cancer. Available at: https://acsearch.acr.org/docs/69459/Narrative/.
55.	Hoyos LR, Benacerraf B, Puscheck EE. Imaging in Endometriosis and Adenomyosis. Clin Obstet Gynecol. 60(1):27-37, 2017 03.
56.	Makled AK, Elmekkawi SF, El-Refaie TA, El-Sherbiny MA. Three-dimensional power Doppler and endometrial volume as predictors of malignancy in patients with postmenopausal bleeding. Journal of Obstetrics & Gynaecology Research. 39(5):1045-51, 2013 May.
57.	El-Sharkawy M, El-Mazny A, Ramadan W, et al. Three-dimensional ultrasonography and power Doppler for discrimination between benign and malignant endometrium in premenopausal women with abnormal uterine bleeding. BMC Women's Health. 16:18, 2016 Mar 16.
58.	Cogendez E, Eken MK, Bakal N, Gun I, Kaygusuz EI, Karateke A. The role of transvaginal power Doppler ultrasound in the differential diagnosis of benign intrauterine focal lesions. Journal of Medical Ultrasonics. 42(4):533-40, 2015 Oct.
59.	Chandavarkar U, Kuperman JM, Muderspach LI, Opper N, Felix JC, Roman L. Endometrial echo complex thickness in postmenopausal endometrial cancer. Gynecologic Oncology. 131(1):109-12, 2013 Oct.
60.	Erdem M, Bilgin U, Bozkurt N, Erdem A. Comparison of transvaginal ultrasonography and saline infusion sonohysterography in evaluating the endometrial cavity in pre- and postmenopausal women with abnormal uterine bleeding. Menopause. 2007; 14(5):846-852.
61.	American College of Radiology. ACR Appropriateness Criteria® Radiation Dose Assessment Introduction. Available at: https://edge.sitecorecloud.io/americancoldf5f-acrorgf92a-productioncb02-3650/media/ACR/Files/Clinical/Appropriateness-Criteria/ACR-Appropriateness-Criteria-Radiation-Dose-Assessment-Introduction.pdf.

Disclaimer

The ACR Committee on Appropriateness Criteria and its expert panels have developed criteria for determining appropriate imaging examinations for diagnosis and treatment of specified medical condition(s). These criteria are intended to guide radiologists, radiation oncologists and referring physicians in making decisions regarding radiologic imaging and treatment. Generally, the complexity and severity of a patient’s clinical condition should dictate the selection of appropriate imaging procedures or treatments. Only those examinations generally used for evaluation of the patient’s condition are ranked. Other imaging studies necessary to evaluate other co-existent diseases or other medical consequences of this condition are not considered in this document. The availability of equipment or personnel may influence the selection of appropriate imaging procedures or treatments. Imaging techniques classified as investigational by the FDA have not been considered in developing these criteria; however, study of new equipment and applications should be encouraged. The ultimate decision regarding the appropriateness of any specific radiologic examination or treatment must be made by the referring physician and radiologist in light of all the circumstances presented in an individual examination.